Open in app

Sign In

Write

Sign In

Dr. Melvin Sanicas
Dr. Melvin Sanicas

412 Followers

Home

About

Apr 24, 2021

Phase 2 trial shows 77% efficacy for malaria vaccine candidate R21

The results of a Phase IIb randomized, controlled, double-blind trial conducted at the Clinical Research Unit of Nanoro (CRUN) / Institut de Recherche en Sciences de la Santé (IRSS), Burkina Faso indicate 77% efficacy over 12 months of follow-up for a vaccine that targets malaria caused by Plasmodium falciparum. The…

Malaria

4 min read

Phase 2 trial shows 77% efficacy for malaria vaccine candidate R21
Phase 2 trial shows 77% efficacy for malaria vaccine candidate R21
Malaria

4 min read


Feb 15, 2021

Small study showed colchicine improved outcomes in hospitalized COVID-19 patients

A small randomized, double-blind clinical trial published in RMD Open showed colchicine to be safe and effective in treating moderate to severe COVID-19 infections in hospitalized patients. In the study, patients who took the inexpensive drug required supplemental oxygen and hospitalization for less time. …

Colchicine

3 min read

Small study showed colchicine improved outcomes in hospitalized COVID-19 patients
Small study showed colchicine improved outcomes in hospitalized COVID-19 patients
Colchicine

3 min read


Jan 12, 2021

Extremely rare case of death from bat rabies in France

Most bats do not have rabies. According to the US Centers for Disease Control and Prevention (CDC), even among bats submitted for rabies testing, only about 6% had rabies. Rabies can only be confirmed in a laboratory but any bat that is active by day or is found in a…

Bats

3 min read

Extremely rare case of death from bat rabies in France
Extremely rare case of death from bat rabies in France
Bats

3 min read


Jan 12, 2021

New TB vaccine, MTBVAC, shows protection against aerosol tuberculosis infection in monkeys

Researchers from Europe and the United States show that a new tuberculosis vaccine, MTBVAC, protects better than the current BCG vaccine in a model of tuberculosis in macaques.

Tuberculosis

3 min read

New TB vaccine, MTBVAC, shows protection against aerosol tuberculosis infection in monkeys
New TB vaccine, MTBVAC, shows protection against aerosol tuberculosis infection in monkeys
Tuberculosis

3 min read


Oct 23, 2020

Finally, an FDA-approved Ebola treatment

Over 2 years since the Kivu Ebola epidemic began in August 2018, the US Food and Drug Administration (FDA) approved the first antibody cocktail for the treatment for Zaire ebolavirus (Ebola virus) infection in adult and pediatric patients. The drug, called Inmazeb, was developed by Regeneron — a biotech company…

Ebola

3 min read

Finally, an FDA-approved Ebola treatment
Finally, an FDA-approved Ebola treatment
Ebola

3 min read


Jun 29, 2020

Studies conclude “COVID toes” are not related to COVID-19

UPDATE [January 2021]: The pathophysiology of chilblains (“COVID toes”) is still widely debated. An association with SARS-CoV-2 infection remains unconfirmed. Conflicting current evidence highlights the need for systematic and repeated testing of larger numbers of patients and the need for valid follow-up data.

Covid-19

4 min read

Studies conclude “COVID toes” are not related to COVID-19
Studies conclude “COVID toes” are not related to COVID-19
Covid-19

4 min read


Jun 3, 2020

Researchers document how asymptomatic COVID-19 cases unknowingly spread the coronavirus

A study published mid-April reported that people infected with SARS-CoV-2, the coronavirus causing COVID-19, might be most contagious during the period before they have symptoms. Two studies published in late May showed that a high percentage of people with COVID-19 could be without symptoms. In one study, Australian researchers reported…

Masks

3 min read

Researchers document how asymptomatic COVID-19 cases unknowingly spread the coronavirus
Researchers document how asymptomatic COVID-19 cases unknowingly spread the coronavirus
Masks

3 min read


May 23, 2020

New study: sunlight can inactivate COVID-19 virus

Previous studies have demonstrated that SARS-CoV-2, the virus that causes COVID-19, is stable on surfaces for extended periods under indoor conditions. A research in China demonstrated sustained coronavirus transmission despite changing weather conditions in different parts of the country that ranged from cold and dry to warm and humid. A…

Covid-19

3 min read

New study: sunlight can inactivate COVID-19 virus
New study: sunlight can inactivate COVID-19 virus
Covid-19

3 min read


May 14, 2020

Phase 2 study shows 3-drug combo shortens COVID-19 viral shedding

A phase 2 trial has shown that a 2-week course of triple antiviral therapy with (1) interferon beta-1b (used to treat the relapsing-remitting and progressive forms of multiple sclerosis), (2) lopinavir-ritonavir (for the treatment of HIV/AIDS) and (3) ribavirin (used to treat chronic hepatitis C and other flavivirus infections) is…

Covid-19

3 min read

Phase 2 study shows 3-drug combo shortens COVID-19 viral shedding
Phase 2 study shows 3-drug combo shortens COVID-19 viral shedding
Covid-19

3 min read


Apr 24, 2020

Zero malaria is still possible — it starts with me

April 25 marks “World Malaria Day,” which is celebrated every year to recognize global efforts to control the disease, to commemorate those who have been affected by it, and to highlight the need for continued investment in and sustained political commitment to malaria prevention and control.

Malaria

3 min read

Zero malaria is still possible — it starts with me
Zero malaria is still possible — it starts with me
Malaria

3 min read

Dr. Melvin Sanicas

Dr. Melvin Sanicas

412 Followers

Physician 🩺 Scientist 🔬 | Writes about vaccines, viruses, infectious diseases, and global health

Following
  • Gideon M-K; Health Nerd

    Gideon M-K; Health Nerd

  • Ashoka

    Ashoka

  • Farooq (SF Ali) 📊🅿️Ⓜ️

    Farooq (SF Ali) 📊🅿️Ⓜ️

  • Dr. Colin Knight

    Dr. Colin Knight

  • Julien Dimastromatteo, PhD

    Julien Dimastromatteo, PhD

See all (47)

Help

Status

Writers

Blog

Careers

Privacy

Terms

About

Text to speech

Teams